Clear answers, sourced.
22 articles on GLP-1 weight loss, longevity for Black women, menopause, hair and skin, peptides, energy and intimacy. Each one answers the question first, then cites its sources.
No articles match. Try another word.
Weight Loss and Longevity for Black Women: What the Research Says
Black women carry a higher burden of obesity and often have longer menopause symptoms, according to CDC and NIH-funded research. Provider-guided GLP-1 care, menopause care and steady habits can support more healthy years, and results vary.
Weight LossSemaglutide vs Tirzepatide: Which GLP-1 Is Right for You?
Both are once-weekly injections that lower appetite. Tirzepatide also acts on GIP, and in a 2025 head-to-head trial of the brand-name medicines it led to greater average weight loss than semaglutide. Side effects are similar, and a licensed provider helps you choose.
Hair and SkinHair Loss in Black Women: Causes, Early Signs and Options
Traction alopecia and CCCA are two common causes of hair loss in Black women, and both are easier to treat early. Pattern thinning at the part or crown may respond to topical minoxidil after a provider review, while scarring types need a dermatologist.
Weight LossGLP-1 Microdosing and Sublingual Drops: What to Know
Microdosing means a lower dose of semaglutide or tirzepatide than standard weight programs use, and sublingual drops are a needle-free form placed under the tongue. Both appeal to women who want a gentler option, but research on either is limited.
Menopause and HormonesHow Do I Know If I'm in Perimenopause? A Symptom Checklist
Most women recognize perimenopause from a pattern of changes, such as shifting cycles, night sweats, poor sleep and mood changes, usually starting in their 40s. No single test confirms it, so tracking symptoms is the most useful first step.
PeptidesGLOW vs KLOW Peptide Blends: What's the Difference?
GLOW combines BPC-157, TB-500 and GHK-Cu. KLOW adds a fourth peptide, KPV, studied for inflammation. Both are compounded, not FDA-approved, and have limited human evidence; the right fit depends on your goals and a provider's review.
Menopause and HormonesThe 2026 HRT Boxed Warning Change, Explained
In November 2025 the FDA began removing boxed warning language about heart disease, breast cancer and dementia from menopause hormone therapy labels, and approved the first six updated labels on February 12, 2026. The endometrial cancer warning stays on estrogen-alone products.
Menopause and HormonesAre Bioidentical Hormones Safer Than Synthetic Hormones?
Not necessarily. Bioidentical means chemically identical to your own hormones, and several FDA-approved products already are. There is no good evidence that compounded bioidentical hormones are safer or more effective than approved hormone therapy.
Menopause and HormonesCan a Blood Test Tell Me If I'm in Perimenopause?
Usually not on its own. FSH and estradiol swing widely during perimenopause, so one result can look normal or postmenopausal depending on the day. Labs are still useful to rule out other causes and to set a baseline.
PeptidesCompounded Medications Explained: 503A vs 503B Pharmacies
A compounded medication is prepared by a pharmacy for a patient's specific prescription. 503A pharmacies compound for individual patients under state boards of pharmacy; 503B outsourcing facilities register with FDA. Neither makes FDA-approved products.
Menopause and HormonesDoes HRT Cause Breast Cancer? What the WHI Study Found
It depends on the type of hormone therapy. In the Women's Health Initiative, estrogen plus progestin was linked to a higher breast cancer risk, while estrogen alone in women without a uterus was linked to a lower risk. Your own risk depends on age, timing and history.
Menopause and HormonesEstradiol Patch, Gel, Cream or Pill: Which Form Is Right for You?
No single form of estradiol is best for everyone. Pills, patches, gels and vaginal creams differ in convenience, how they reach the bloodstream and some risks, and a licensed provider helps you choose based on your symptoms and history.
SkinGHK-Cu Cream vs Injection: What Is the Difference?
Topical GHK-Cu has decades of use and small human studies; injected GHK-Cu has few published human studies. The cream fits a skincare routine, the injection is a self-injection, and both are compounded and not FDA-approved.
SkinGHK-Cu vs Retinol vs Vitamin C: Which Is Best for Wrinkles?
Retinoids have the largest body of evidence for fine wrinkles from sun damage. Vitamin C is a well-studied antioxidant that supports collagen. GHK-Cu copper peptide is gentler, but its human evidence is smaller and less consistent.
SkinHow Menopause Changes Your Skin, and What Helps
Falling estrogen affects skin thickness, collagen, moisture and elasticity, so many women notice drier, thinner skin around menopause. Daily sunscreen and retinoids have the strongest evidence; hormone therapy is not recommended for wrinkles alone.
EnergyHow to Give Yourself a Subcutaneous Injection
Subcutaneous injections go into the fatty layer under the skin, usually the belly or thigh, with a small needle. Follow the step-by-step directions that come with your prescription, rotate sites, and never reuse or share needles.
SkinHow to Layer GHK-Cu With Retinol, Vitamin C and Acids
Many routines combine copper peptides with retinoids or vitamin C by using them at different times of day. Strong acids and pure vitamin C are acidic and may affect copper peptide stability, so they are usually kept in separate steps.
SkinHow to Use GHK-Cu Cream: Timing, Amount and What to Expect
Follow the directions on your prescription label. Copper peptide creams are generally applied to clean, dry skin, often once a day, before moisturizer, with daily sunscreen in the morning. Changes, if any, are usually measured over about 8 to 12 weeks.
IntimacyHow to Use PT-141 (Bremelanotide): Timing and Side Effects
PT-141 is taken as needed, injected under the skin at least 45 minutes before sexual activity according to the FDA-approved label. Nausea is the most common side effect, and it can briefly raise blood pressure.
IntimacyLow Libido in Women: Causes and Treatment Options
Low desire is common and has many causes, including stress, sleep, relationships, medications and hormones. Options range from addressing those causes and sex therapy to FDA-approved medicines such as bremelanotide (PT-141) and flibanserin for some premenopausal women.
EnergyNAD+ Injection vs Nasal Spray: Which Is Better?
There is not enough human research to say one form works better. Most NAD+ research in people has studied oral precursors, not injections or sprays, so the choice usually comes down to comfort with needles, convenience, cost and your provider's advice.
Menopause and HormonesTestosterone for Women: Evidence, Side Effects and Status
Testosterone can modestly improve low desire in some postmenopausal women, according to a 2019 global consensus, but there is no FDA-approved testosterone product for women in the US. Golden Glow does not currently offer testosterone.